Treatment of Infective Exacerbation of Bronchiectasis

Introduction to Treatment

• The British Thoracic Society recommends treating acute exacerbations with 14 days of oral antibiotics, selecting the agent based on prior sputum microbiology and risk factors for Pseudomonas aeruginosa infection 1, 2

Immediate Management Steps

• Collect sputum for culture and sensitivity testing prior to commencing antibiotics, particularly in patients requiring hospitalization, and start empirical antibiotics immediately while awaiting microbiology results 1
• Modify antibiotic selection once pathogen is isolated if there is no clinical improvement, guided by sensitivity results 1

Antibiotic Selection

• For patients without Pseudomonas aeruginosa risk factors, the European Respiratory Society suggests the following antibiotic regimens:
• For patients with Pseudomonas aeruginosa, the British Thoracic Society recommends:

Duration of Treatment

• The British Thoracic Society and European Respiratory Society recommend 14 days of antibiotic therapy for acute exacerbations, based on expert consensus and studies demonstrating good clinical outcomes 1, 2, 3, 4
• Exceptions where duration may be modified: shorter courses for mild exacerbations or longer courses for severe exacerbations or inadequate response to treatment 2, 4

Special Considerations

• For new isolation of Pseudomonas aeruginosa, offer eradication antibiotic treatment, with first-line ciprofloxacin 500-750 mg twice daily for 2 weeks 1, 2
• For new growth of MRSA with clinical deterioration, offer eradication treatment, with oral doxycycline 100 mg twice daily for 14 days (first-line) 1

Common Pitfalls to Avoid

• Do not use inhaled corticosteroids for bronchiectasis exacerbations unless the patient has comorbid asthma or COPD 2, 3
• Avoid statins for bronchiectasis treatment 2, 3
• Re-evaluate patients who fail to respond by day 14: obtain repeat sputum culture, reassess for non-infectious causes, and consider antibiotic change with broader coverage 5

Patient Self-Management

• Provide patients with a self-management plan that includes prompt treatment of exacerbations, antibiotics to keep at home, and clear instructions on when to initiate treatment 1

Antibiotic Recommendations for Bronchiectasis Exacerbations in Patients with Multiple Drug Allergies

Oral Antibiotic Options (Mild‑Moderate Exacerbations)

Adjunctive Therapy for Pseudomonas aeruginosa (Oral Setting)

Intravenous Antibiotic Options (Severe Exacerbations or Hospitalization)

Treatment Duration

Monitoring and Adjustment

Allergy Evaluation

Rescue Strategy When Standard Options Fail

Acute Bronchiectasis Exacerbation – Evidence‑Based Management Recommendations

Diagnostic Approach

• Obtain sputum for culture and sensitivity before starting antibiotics, especially in hospitalized individuals, to enable targeted therapy if the initial regimen fails. 10
• If the initial empiric regimen does not lead to clinical improvement, modify antibiotic choice according to the isolated pathogen and its susceptibility profile. 10

Empiric Antibiotic Selection

Patients without Pseudomonas aeruginosa risk factors

• First‑line oral therapy: Amoxicillin‑clavulanate 625 mg three times daily for 14 days, covering Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. [11][12]

Patients with Pseudomonas aeruginosa risk or prior isolation

• Mild‑to‑moderate exacerbations: Oral ciprofloxacin 500–750 mg twice daily for 14 days. 10

Adjunctive Airway‑Clearance Measures

• Increase the frequency of airway‑clearance techniques during an acute exacerbation compared with the patient’s baseline regimen. [11][12]
• Administer a short‑acting β₂‑agonist before airway‑clearance sessions to facilitate sputum expectoration. [11][12]

Treatment Duration

• Standard course: 14 days of antibiotics for all exacerbations, based on expert consensus and clinical outcome data. [10][13]
• Shorter courses (≤10 days) may be considered for mild exacerbations with rapid return to baseline, although supporting evidence is limited. 13
• Extended courses (>14 days) may be required for severe exacerbations or when there is inadequate response at day 14. 13

Management of Treatment Failure

• At day 14, if no clinical improvement is observed, repeat sputum culture and sensitivity testing and reassess for non‑infectious causes. 10
• Escalate to broader‑spectrum antibiotics guided by the repeat culture results when treatment failure is confirmed. 10

Eradication of Newly Isolated Pathogens

• First isolation of Pseudomonas aeruginosa: Initiate eradication therapy with oral ciprofloxacin 500–750 mg twice daily for 2 weeks (first‑line). [10][13]
• Prompt eradication is recommended immediately after confirming P. aeruginosa presence to prevent chronic colonisation. [11][12]

Patient Self‑Management Plan

• Provide patients with a supply of antibiotics for home use, enabling rapid self‑initiation of treatment at the first sign of an exacerbation. 10
• Educate patients to recognise exacerbation symptoms: acute worsening of cough, increased sputum volume or purulence, heightened breathlessness, or systemic upset. 10